Biosensors International Group

Biosensors International Group, Ltd. is a Singapore-based company that specializes in the development, manufacturing, and marketing of medical devices used in interventional cardiology and critical care procedures. The company operates in four main segments: Interventional Cardiology, Critical Care, Cardiac Diagnostic, and Licensing Revenue. Its Interventional Cardiology segment offers a range of proprietary drug-eluting stents and coronary bare-metal stents, alongside various catheter systems and angioplasty balloons. The Critical Care segment provides essential catheter systems and accessories for surgical and intensive care applications, including blood pressure transducers and central venous catheters. Additionally, the Cardiac Diagnostic segment focuses on medical imaging and clinical applications, while the Licensing Revenue segment involves licensing its proprietary technologies. Established in 1990, Biosensors International Group has a global presence, including significant operations in China and Japan, and is a subsidiary of Blue Sail Medical Co., Ltd.